| Mr Timothy P Young, MD | |
|
70 Butler St., Salem, NH 03079 | |
| (603) 893-2900 | |
| (603) 893-1628 |
| Full Name | Mr Timothy P Young |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 70 Butler St., Salem, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265454664 | NPI | - | NPPES |
| 1023289300001 | Medicaid | PA | |
| 1423K | Other | NC | NCBCBS |
| 5904301 | Medicaid | NC | |
| N0082B | Medicaid | SC | |
| 0203238 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 200600824 (North Carolina) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | MD436939 (Pennsylvania) | Primary |
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).
Sydney-based, ASX listed, biopharmaceutical company, Medlab Clinical Ltd has been granted ethics approval to progress to two separate human trials using its nanotechnology delivery platform.
NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
Plymouth University has received funding in excess of £1.2M from the Higher Education Funding Council for England to support capital investment for teaching facilities in existing and proposed laboratories, at the headquarters of Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), Plymouth Science Park.
Only one in five patients eligible for a free "midlife MOT" on the NHS took up the offer in the first four years of the programme.
› Verified 1 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).
Sydney-based, ASX listed, biopharmaceutical company, Medlab Clinical Ltd has been granted ethics approval to progress to two separate human trials using its nanotechnology delivery platform.
NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
Plymouth University has received funding in excess of £1.2M from the Higher Education Funding Council for England to support capital investment for teaching facilities in existing and proposed laboratories, at the headquarters of Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), Plymouth Science Park.
Only one in five patients eligible for a free "midlife MOT" on the NHS took up the offer in the first four years of the programme.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Timothy P Young, MD 70 Butler St., Salem, NH 03079 Ph: (603) 893-2900 | Mr Timothy P Young, MD 70 Butler St., Salem, NH 03079 Ph: (603) 893-2900 |
News Archive
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).
Sydney-based, ASX listed, biopharmaceutical company, Medlab Clinical Ltd has been granted ethics approval to progress to two separate human trials using its nanotechnology delivery platform.
NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
Plymouth University has received funding in excess of £1.2M from the Higher Education Funding Council for England to support capital investment for teaching facilities in existing and proposed laboratories, at the headquarters of Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), Plymouth Science Park.
Only one in five patients eligible for a free "midlife MOT" on the NHS took up the offer in the first four years of the programme.
› Verified 1 days ago
Christina J Cote, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Nrhn Rehab Physician Services, 70 Butler Street, Salem, NH 03079 Phone: 603-501-5547 Fax: 603-501-5650 | |
Dr. Chris Chheang Tourt, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 70 Butler St, Salem, NH 03079 Phone: 603-893-2900 | |
Dr. Scott Robert Masterson, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10 Cortland Drive, Salem, NH 03079 Phone: 603-365-7548 |